Quarterly Result4 Nov 2026, 02:32 pm
Alembic Pharma Declares Unaudited Q2 FY27 Results
AI Summary
Alembic Pharmaceuticals Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved both consolidated and standalone results, along with the limited review report from statutory auditors. The board meeting commenced at 11:30 a.m. and concluded at 2:10 p.m. The company operates in the pharmaceuticals business with a single reportable segment.
Key Highlights
- Alembic Pharma announced unaudited financial results.
- Results cover the quarter and half-year ended September 30, 2026.
- Consolidated and standalone results were approved.
- Statutory auditors provided a limited review report.
- The company operates in a single reportable segment.
Price Impact
More from APLLTD